Technology | February 14, 2011

New 5 French Catheter Minimizes Risk of Vessel Trauma

Stock image

February 14, 2011 – A new bedside insertion kit and power-injectable catheter has been launched. The Morpheus Smart PICC insertion kit and 5 French Dual Lumen Peripherally Inserted Central Catheter (PICC), from AngioDynamics, are an extension of the company’s Morpheus Smart PICC line.

The 5 French power-injectable catheter is designed to provide a superior flow rate of 5 mL/second for purposes of CT imaging. This performance upgrade is coupled with the pushability needed for PICC placement with pliability that minimizes the risk of vessel trauma and phlebitis. It also employs Smart Taper technology, which is designed to reduce the risk of thrombosis by allowing the catheter’s diameter to quickly taper from 7 French to a precise 5 French.

“Our facility conducts more than 3,500 PICC placements per year,” said Julie Amicucci, chief, emergency center physician extenders and director of the PICC Team at William Beaumont Hospital, Royal Oak, Mich. “After switching to AngioDynamics, we’ve seen a reduced number of calls involving post procedure bleeding.”

Amicucci said her facility also will experience benefits from the new Morpheus Smart PICC bedside insertion kit, which includes upgraded premium safety components. Specifically, the safety components include a new sharps container, upgraded safety scalpel, safety needles, larger absorbent drapes to protect the sterile field and two ChloraPrep One-Step Applicators for maximum site preparation coverage. This new kit was designed to allow for safer, more efficient PICC placements at the patient’s bedside.

“When traveling from bedside to bedside in a clinical setting, it is the little things that make the difference,” she said. “The new AngioDynamics insertion kit is slimmer, which will allow us to store more kits per cart, and it has everything that is required for the procedure. This will allow us to provide better patient care by getting to patients faster, ultimately saving time and the hospital money.”

For more information:

Related Content

the Contrast Media Injectors Market is estimated to be USD 1.3 billion in 2020 and  projected to reach $1.9B by 2025, at a CAGR of 7.4% between 2020 and 2025

Getty Images

News | Contrast Media Injectors | September 02, 2020
September 2, 2020 — According to the new market research report "...
The Global Contrast Injectors Market will grow by $613.47M during 2020-2024, according to Technavio
News | Contrast Media Injectors | June 17, 2020
June 17, 2020 — Technavio has been monitoring the ...
The FDA has approved Lilly’s TAUVID (flortaucipir F 18 injection), a radioactive diagnostic agent, for PET imaging of the brain to estimate the density and distribution of aggregated tau neurofibrillary tangles (NFTs) in adult patients with cognitive impairment who are being evaluated for Alzheimer’s disease

Getty Images

News | Contrast Media | June 01, 2020
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for...
This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma

This image is of an 80 kg woman with a newly diagnosed IDH-wildtype glioblastoma. The quarter dose image on the left was obtained after the administration of 4 ml of MultiHance. Subsequently, an additional 12 ml of MultiHance was administered and the cumulative full dose image in the center was obtained. The image on the right was rendered following artificial intelligence processing of the 4 ml image using eGad genetic algorithms. This image has the quality of triple dose gadolinium even though only one quarter dose gadolinium was given.

Feature | Contrast Media Injectors | January 30, 2020 | By Matthew Kuhn, M.D., FACR
Gadolinium-based contrast agents (...

Image courtesy of Guerbet

Feature | Contrast Media Injectors | January 30, 2020 | By Melinda Taschetta-Millane
Contrast media injector technology has seen several recent advances, such as cutting costs by reducing contrast waste

Guerbet presented its Contrast&Care injection management solution at ECR 2018

News | Contrast Media | November 13, 2019
November 13, 2019 – Guerbet, a global specialist in...
Windsong Radiology Group

Windsong Radiology Group

Sponsored Content | Case Study | Contrast Media Injectors | October 30, 2019
Windsong Radiology Group is a New York-based radiolo